Fluticasone propionate hydrofluoroalkane inhalation (GSK)

丙酸氟替卡松氢氟烷烃吸入剂 (葛兰素史克)

Report date: 2025/07/17 10:38:31

Base Information

Drug NameFluticasone propionate hydrofluoroalkane inhalation (GSK)
Drug Alias NameFluticasone propionate HFA inhalationFLOVENT HFA
ClassificationSmall molecules > Steroids
Mechanisms of ActionCytosolic phospholipase A2 agonistsGlucocorticoid receptor agonists
TargetsCytosolic phospholipase A2Glucocorticoid receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsAsthma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2004/05/14
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxo Group Ltd
Inactive CompaniesN/A
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A